Warburton Capital Management, LLC

Position in MRK — Merck & Co., Inc.

CIK 2054795 TULSA, OK

Position in MRK

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$207,013

New position

Shares Held

1,611

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.60%

of 13F equity value

Holder Rank

#3,488

of 3,769 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Warburton Capital Management, LLC holds $1,474,189 across 5 Drug Manufacturers - General names. MRK ranks #5 (14.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	472	$566,131
2	JNJ	Johnson & Johnson	1,006	$255,493
3	ABBV	AbbVie Inc.	897	$225,721
4	GILD	Gilead Sciences, Inc.	1,740	$219,831
5	MRK	Merck & Co., Inc. This page	1,611	$207,013

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$207,013	1,611	—	Shares	Sole	2026-08-03
No filing history on record for this holder in this stock.